Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Semaglutide study raises new questions about pregnancy safety

A small sheep study found that semaglutide reduced maternal cardiac output, uterine blood flow, and fetal oxygen levels within two

TR
By Tom Reyes · Markets Editor
Nov 10 09:30 ETSource: Earth.com

From the source

Semaglutide study raises new questions about pregnancy safety

A small sheep study found that semaglutide reduced maternal cardiac output, uterine blood flow, and fetal oxygen levels within two hours.

Read at earth.com
PeptiPrescribed peptides from $99/moSee all →